RELMABI Trademark
Trademark Overview
On Thursday, September 4, 2025, a trademark application was filed for RELMABI with the United States Patent and Trademark Office. The USPTO has given the RELMABI trademark a serial number of 99374398. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, June 3, 2026. This trademark is owned by Teva Pharmaceuticals International GmbH. The RELMABI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
General Information
| Serial Number | 99374398 |
| Word Mark | RELMABI |
| Filing Date | Thursday, September 4, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, June 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 23, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 4, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Jona 8645
CH |
Trademark Events
| Event Date | Event Description |
| Thursday, September 4, 2025 | NEW APPLICATION ENTERED |
| Thursday, September 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, January 20, 2026 | ASSIGNED TO EXAMINER |
| Thursday, January 22, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, January 22, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, January 22, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 11, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 11, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 11, 2026 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, February 11, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, May 8, 2026 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, May 8, 2026 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, May 21, 2026 | TEAS PETITION TO REVIVE RECEIVED |
| Thursday, May 21, 2026 | PETITION TO REVIVE-GRANTED |
| Thursday, May 21, 2026 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, May 21, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 21, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 21, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 28, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
